Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...

Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials.

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...